到 2028 年美国皮肤科非处方药市场预测 - COVID-19 影响和按产品类型（片剂和胶囊、油、凝胶、面霜和软膏、其他）进行的国家分析；适应症（皮炎、痤疮、牛皮癣、皮肤漂白、抗真菌、除疣、其他）；给药途径（局部、口服）；分销渠道（在线分销、医院和零售药店、超级市场）
No. of Pages: 140 | Report Code: TIPRE00022065 | Category: Life Sciences
No. of Pages: 140 | Report Code: TIPRE00022065 | Category: Life Sciences
皮肤科是从事各种皮肤相关疾病的诊断、预防和治疗的医学领域疾病，如色素沉着、痤疮、皱纹和牛皮癣。非处方药是可供公众安全有效使用的药物，无需寻求医疗专业人员的治疗。美国皮肤科非处方药市场的增长主要归因于皮肤异常患病率的上升以及皮肤科非处方药（OTC）供应量的增加。此外，预计不断增长的场外交易市场将进一步促进预测期内的市场增长。然而，与非处方皮肤科药物相关的副作用（例如皮肤过敏）限制了市场的增长。
COVID-19 已经影响了美国大量人口，导致对流行非处方药的需求空前激增。消费者似乎试图自己解决疾病症状，以避免去看医生。保持社交距离和居家令迫使消费者以不同的方式购物。此外，连续使用口罩和经常洗手会导致皮肤刺激和口罩。经常洗手导致皮肤干燥和湿疹等病症增加，这导致对皮肤科非处方药产品的需求增加。
美国皮肤科非处方药市场预计将从 2020 年的 9.5297 亿美元增至 2028 年的 11.2456 亿美元。该市场预计将以 2.1 的复合年增长率增长% 从 2021 年到 2028 年。推动市场增长的因素是皮肤异常患病率上升以及皮肤科非处方药 (OTC) 供应量的增加。然而，与非处方皮肤科药物相关的副作用（例如皮肤过敏）可能会对市场增长产生负面影响。
从产品类型来看，乳霜和软膏细分市场在2020年美国皮肤科非处方药市场中占据最大份额。就适应症而言，皮炎细分市场占据美国皮肤科非处方药市场的最大份额。根据给药途径，外用细分市场在美国皮肤科非处方药市场中占有较大份额。从分销渠道来看，医院和零售药房市场占据最大份额。
在准备美国皮肤科非处方药市场报告时提到的一些主要一手和二手来源是世界卫生组织和疾病预防和控制中心。
美国皮肤科非处方药市场细分
按产品类型
按适应症
按给药途径
按分销渠道
公司简介
Strategic insights for US Dermatology OTC Medications involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 952.97 Million |
| Market Size by 2028 | US$ 1,124.56 Million |
| Global CAGR (2021 - 2028) | 2.1% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2028 |
| Segments Covered |
By 产品类型
|
| Regions and Countries Covered | 美国
|
| Market leaders and key company profiles |
The regional scope of US Dermatology OTC Medications refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - US Dermatology OTC Medications Market
The US Dermatology OTC Medications Market is valued at US$ 952.97 Million in 2020, it is projected to reach US$ 1,124.56 Million by 2028.
As per our report US Dermatology OTC Medications Market, the market size is valued at US$ 952.97 Million in 2020, projecting it to reach US$ 1,124.56 Million by 2028. This translates to a CAGR of approximately 2.1% during the forecast period.
The US Dermatology OTC Medications Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the US Dermatology OTC Medications Market report:
The US Dermatology OTC Medications Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The US Dermatology OTC Medications Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the US Dermatology OTC Medications Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For US Dermatology OTC Medications Market
